Forensic Analysis · General / Diversified · as of Jun 27, 2026
Concentrix Corp (CNXC)
A forensic read on Concentrix Corp built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
B · Sound & dependable
Forensic grade
Distress
Financial health
0.3
Altman Z-score
Clean
Earnings quality
4
Forensic signals
-37.5%
ROE
$1.5B
Market cap
5.90%
Dividend yield
Concentrix Corp earns a B (Sound & dependable) forensic quality grade, and its Altman Z-score is 0.3, placing it in the Distress zone. 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-9%Return on invested capital.Return on invested capital is -9% and slipping from 9% — well below its ~9% cost of capital, so reinvested dollars may be destroying value, not building it.
+7.3%/yrShare-count dilution.Diluted share count changed +22% over the last 3 years to FY2025 (+7.3%/yr). The count is GROWING — existing holders are being diluted. That's ~7.3% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2022 has been diluted ~22%.
1% of revStock-based comp load.Stock-based compensation ran 1% of revenue and 17% of free cash flow in FY2025 — about $1.53 per diluted share. Meaningful — reported free cash flow flatters the economics, since SBC is a real cost paid in shares.
$1.5BGoodwill impairments.Took $1.5B of goodwill writedowns across 1 year(s) (FY2025 ($1.5B)). Writedowns mean past acquisitions underperformed what was paid for them — worth weighing on capital-allocation skill.
Key fundamentals
Net Margin-13.0%
Debt / Equity1.69x
Free Cash Flow$572.5M
Latest Revenue$9.83B
Return on Equity-46.6%
Revenue Growth YoY+2.2%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on Concentrix Corp:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about CNXC's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown